137 related articles for article (PubMed ID: 26621118)
1. Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f® in healthy women after follicle-stimulating hormone downregulation.
Lammerich A; Mueller A; Bias P
Reprod Biol Endocrinol; 2015 Dec; 13():130. PubMed ID: 26621118
[TBL] [Abstract][Full Text] [Related]
2. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
[TBL] [Abstract][Full Text] [Related]
3. Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.
Lammerich A; Bias P; Gertz B
Int J Womens Health; 2015; 7():707-16. PubMed ID: 26213478
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pharmacokinetic and safety profiles between Bemfola(®) and Gonal-f(®) after subcutaneous application.
Wolzt M; Gouya G; Sator M; Hemetsberger T; Irps C; Rettenbacher M; Vcelar B
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):259-65. PubMed ID: 25633239
[TBL] [Abstract][Full Text] [Related]
5. XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders.
Hoy SM
BioDrugs; 2016 Aug; 30(4):379-86. PubMed ID: 27342604
[TBL] [Abstract][Full Text] [Related]
6. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jan; 14():1. PubMed ID: 26733057
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
Picard M; Rossier C; Papasouliotis O; Lugan I
Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
[TBL] [Abstract][Full Text] [Related]
8. Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study.
Kaplan S; Levy-Toledano R; Davies M; Roy D; Howles CM; Lass A
Front Endocrinol (Lausanne); 2021; 12():632674. PubMed ID: 33815290
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation.
Liedert B; Forssmann U; Wolna P; Golob M; Kovar A
BMC Clin Pharmacol; 2010 Oct; 10():14. PubMed ID: 20961422
[TBL] [Abstract][Full Text] [Related]
12. Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris
Bagchus W; Yalkinoglu Ö; Wolna P
Front Endocrinol (Lausanne); 2017; 8():371. PubMed ID: 29375477
[TBL] [Abstract][Full Text] [Related]
13. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
14. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
[TBL] [Abstract][Full Text] [Related]
15. Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap
Winstel R; Wieland J; Gertz B; Mueller A; Allgaier H
Drugs R D; 2017 Jun; 17(2):305-312. PubMed ID: 28386738
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime®) vs. Gonal-f® in women undergoing ovarian stimulation for IVF: A randomized, multicenter, evaluator-blinded, non-inferiority study.
Pasqualini A; Ruhlmann C; Botti GA; Estofán DE; Pasqualini S; Inciarte F; Ruhlmann F; Lopez C; Palena C; Klimovsky E; Federico A; Gonzalez E; Cordeiro L; Lago N
JBRA Assist Reprod; 2021 Oct; 25(4):524-532. PubMed ID: 34338481
[TBL] [Abstract][Full Text] [Related]
17. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.
Fisch B; Avrech OM; Pinkas H; Neri A; Rufas O; Ovadia J; Loumaye E
J Assist Reprod Genet; 1995 Jan; 12(1):26-31. PubMed ID: 7580006
[TBL] [Abstract][Full Text] [Related]
18. In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f).
Mastrangeli R; Satwekar A; Cutillo F; Ciampolillo C; Palinsky W; Longobardi S
PLoS One; 2017; 12(9):e0184139. PubMed ID: 28880909
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
20. Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects.
Wang J; Yang T; Mei H; Yu X; Peng H; Wang R; Cai Y
Drug Des Devel Ther; 2020; 14():435-444. PubMed ID: 32099328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
